The SHH signaling pathway is involved in normal embryogenesis development and plays a key role in the promotion of tumor growth and in drug resistance, upregulating the genes involved in CSC maintenance, such as CD44, CCND2, c-MYC, NANOG, OCT4, and ALDH1 [49,50]. Here, CD44 is linked to neoplasm.